The effects of antiepileptic drugs on vascular risk factors: a narrative review.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Seizure

• Publication date

  2014-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.seizure.2014.05.011PMID 25028247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atherogenic consequence of antiepileptic drugs: a study of intima-media thickness

  2014cited by this paper
• Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.

  2014cited by this paper
• Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy

  2013cited by this paper
• Metabolic biomarkers for predicting cardiovascular disease

  2013cited by this paper
• Epilepsy Associated with Systemic Autoimmune Disorders

  2013cited by this paper
• Metabolic and endocrine effects of valproic acid chronic treatment.

  2013cited by this paper
• Brain arteriovenous malformations and seizures: an Italian study

  2013cited by this paper
• Hyperuricaemia: more than just a cause of gout?

  2013cited by this paper
• Leukocyte trafficking mechanisms in epilepsy.

  2013cited by this paper
• Seizures after cerebrovascular events: risk factors and clinical features.

  2013cited by this paper
• Enzyme induction with antiepileptic drugs: Cause for concern?

  2013cited by this paper
• The Role of Carotid Intimal Thickness and Plaque Imaging in Risk Stratification for Coronary Heart Disease

  2012cited by this paper
• Cardiac Troponin I elevation after epileptic seizure

  2012cited by this paper
• Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy.

  2012cited by this paper
• Metabolic syndrome among Chinese obese patients with epilepsy on sodium valproate.

  2012cited by this paper
• Effects of long‐term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis

  2012cited by this paper
• Characterization of glucose homeostasis and lipid profile in adult, seizure‐free, epileptic patients in Asian population

  2012cited by this paper
• Do antiepileptic drugs or generalized tonic–clonic seizure frequency increase SUDEP risk? A combined analysis

  2012cited by this paper
• Oxidative stress biomarkers as predictors of cardiovascular disease.

  2011cited by this paper
• Sudden unexpected death in epilepsy (SUDEP) and sleep.

  2011cited by this paper
• Nonalcoholic fatty liver disease in adolescents receiving valproic acid.

  2011cited by this paper
• Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte–endothelial interactions

  2011cited by this paper
• Combined analysis of risk factors for SUDEP

  2011cited by this paper
• Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy.

  2011cited by this paper
• Adjunctive antiepileptic drug therapy and prevention of SUDEP.

  2011cited by this paper
• The long-term risk of premature mortality in people with epilepsy.

  2011cited by this paper
• Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors.

  2011cited by this paper
• Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis.

  2011cited by this paper
• Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?

  2011cited by this paper
• Matrix metalloproteinases in vascular disease--a potential therapeutic target?

  2010cited by this paper
• Gout, Hyperuricemia, and the Risk of Cardiovascular Disease: Cause and Effect?

  2010cited by this paper
• The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy.

  2010cited by this paper
• Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.

  2010cited by this paper
• Cardiac involvement in systemic rheumatic diseases: An update.

  2010cited by this paper
• Epilepsy and the heart

  2010cited by this paper
• Antiepileptic Drugs and Markers of Vascular Risk

  2010cited by this paper
• Epileptic seizures increase circulating endothelial cells in peripheral blood as early indicators of cerebral vascular damage.

  2010cited by this paper
• Metabolic consequences of antiepileptic drugs

  2010cited by this paper
• Vitamin D and metabolic syndrome: is there a link?

  2010cited by this paper
• Benefits of sunlight: vitamin D deficiency might increase the risk of sudden unexpected death in epilepsy.

  2010cited by this paper
• Exercise Prescription and Primary Prevention of Cardiovascular Disease

  2010cited by this paper
• Homocysteine metabolism and its relation to health and disease

  2010cited by this paper
• Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine

  2010cited by this paper
• The metabolic syndrome in overweight epileptic patients treated with valproic acid

  2010cited by this paper
• Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs

  2010cited by this paper
• The effect of smoking on arterial stiffness

  2010cited by this paper
• Sudden Unexpected Death in Epilepsy

  2010cited by this paper
• Homocysteine Potentiates Seizures and Cell Loss Induced by Pilocarpine Treatment

  2010cited by this paper
• Obesity and arterial compliance alterations.

  2010cited by this paper
• Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.

  2010cited by this paper
• Statins in epilepsy

  2010cited by this paper
• Biomarkers of inflammation and oxidative stress in atherosclerosis.

  2010cited by this paper
• Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: a possible role in homeostatic synaptic plasticity.

  2010cited by this paper
• Statin use and risk of epilepsy

  2010cited by this paper
• Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients

  2010cited by this paper
• Lipoprotein a: where are we now?

  2009cited by this paper
• Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?

  2009cited by this paper
• Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): III. Vitamin K, folic acid, blood levels, and breast‐feeding

  2009cited by this paper
• Effects of Seizures on Cardiac Function

  2009cited by this paper
• Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms

  2009cited by this paper
• Is asymmetric dimethylarginine responsible for the vascular events in patients under antiepileptic drug treatment?

  2009cited by this paper
• Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment.

  2009cited by this paper
• C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease.

  2009cited by this paper
• Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid.

  2009cited by this paper
• Comorbidity, health screening, and quality of life among persons with a history of epilepsy.

  2009cited by this paper
• Effects of antiepileptic drugs on lipids, homocysteine, and C‐reactive protein

  2009cited by this paper
• Folic acid supplementation for women with epilepsy who might become pregnant

  2009cited by this paper
• Is there a role for supplemented antioxidants in the prevention of atherosclerosis?

  2009cited by this paper
• Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--the Stockholm Heart Epidemiology Program.

  2009cited by this paper
• The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre.

  2009cited by this paper
• Long‐term antiepileptic drug therapy contributes to the acceleration of atherosclerosis

  2009cited by this paper
• Increased risk of vascular events in systemic lupus erythematosus: is arterial stiffness a predictor of vascular risk?

  2008cited by this paper
• Bone health in women with epilepsy: clinical features and potential mechanisms.

  2008cited by this paper
• Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death.

  2008cited by this paper
• Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality.

  2008cited by this paper
• Oral valproic acid for epilepsy--long-term experience in therapy and side effects.

  2008cited by this paper
• Homocysteine Activates Platelets In Vitro

  2008cited by this paper
• Exercise, diet, health behaviors, and risk factors among persons with epilepsy based on the California Health Interview Survey, 2005.

  2008cited by this paper
• Pleiotropic effects of thiazolidinediones

  2008cited by this paper
• Inflammation, C-reactive protein, and atherothrombosis.

  2008cited by this paper
• Do we need to consider inflammatory markers when we treat atherosclerotic disease?

  2008cited by this paper
• Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 Behavioral Risk Factor Surveillance System.

  2008cited by this paper
• Do Different Vascular Risk Factors Affect All Arteries Equally?

  2008cited by this paper
• C-reactive protein (CRP): more than just an innocent bystander?

  2008cited by this paper
• Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality

  2008cited by this paper
• Oral valproic acid for epilepsy - long-term experience in therapy and side effects

  2008cited by this paper
• SUDEP in the Netherlands: a retrospective study in a tertiary referral center.

  2007cited by this paper
• Valproate, weight gain and carbohydrate craving: a gender study.

  2007cited by this paper
• Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia

  2007cited by this paper
• Excess body weight and risk of first‐ever acute ischaemic non‐embolic stroke in elderly subjects

  2007cited by this paper
• Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy

  2007cited by this paper
• Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions.

  2007cited by this paper
• The effect of antiepileptic drugs on vitamin B12 metabolism

  2007cited by this paper
• Antiepileptic Drugs and MTHFR Polymorphisms Influence Hyper‐Homocysteinemia Recurrence in Epileptic Patients

  2007cited by this paper
• Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA.

  2007cited by this paper
• Cardiovascular risk factors and homocysteine in epilepsy.

  2007cited by this paper
• Weight issues for people with epilepsy—A review

  2007cited by this paper
• Natural approaches to epilepsy.

  2007cited by this paper
• The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect.

  2007cited by this paper
• Inhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patients

  2007cited by this paper

• Epileptic seizures in patients with stroke

  2026cites this paper
• Cenobamate beyond Epilepsy: exploring associations with vascular risk factors through serological markers.

  2026cites this paper
• Time-dependent risk of stroke following epilepsy: A nationwide cohort study in South Korea.

  2025cites this paper
• Role of different anti-seizure medications on carotid intima–media thickness: A systematic review and meta-analysis

  2025cites this paper
• Outcomes after cardiac surgery in patients with epilepsy: A nationwide analysis

  2025cites this paper
• Effects of Antiseizure Medications on Lipid Profile and Weight in Patients with Epilepsy: A Systematic Review with Meta-analysis

  2025cites this paper
• Antiseizure medications for primary and secondary seizure prevention after stroke

  2025cites this paper
• Mechanistic insights into the sleep-glymphopathy-cerebral small vessel disease loop: implications for epilepsy pathophysiology and therapy

  2025cites this paper
• Epilepsy Comorbidities

  2025cites this paper
• Comparative study on autonomic dysfunction in idiopathic generalized epilepsy

  2025cites this paper
• Antiseizure medications and their differing effects on cardiovascular risk

  2025cites this paper
• Causal relations between ischemic stroke and epilepsy: A bidirectional Mendelian randomization study

  2024cites this paper
• Epilepsy of aging: an increasing challenge of the 21st century

  2024cites this paper
• Current Paradigms in Understanding Neuron Fluctuations, Factors, Regulation, Pathophysiology of Epilepsy: Advancements in Diagnosis, Treatment and Management—An Update

  2024cites this paper
• The effect of the modified Atkins diet and anti-seizure medications on lipid marker levels in adults with epilepsy

  2024cites this paper
• Inflammatory and oxidative stress biomarkers in children and adolescents with bipolar disorder - A systematic review and meta-analysis.

  2024cites this paper
• Morphological and histopathological changes of maternal levetiracetam on the cerebellar cortex of the offspring of albino rat

  2024cites this paper
• Evaluation of anti-seizure medications and their serum concentration with regard to cardiovascular risk parameters: A cross-sectional study.

  2024cites this paper
• Circadian rhythm of blood pressure in patients with drug-resistant mesial temporal lobe epilepsy.

  2023cites this paper
• Assessment of Topiramate VS Valproate Effects on Serum Lipid Profile in Young Adults with Epilepsy : A Retrospective Study

  2023influential citation
• Comparative vascular effects of levetiracetam and valproate with hyperhomocysteinemia in rat models

  2023cites this paper
• Post-stroke epilepsy: From clinical predictors to possible mechanisms.

  2023cites this paper
• Demenzrisiko bei fokaler Epilepsie

  2023cites this paper
• A Leading Cause of Epilepsy

  2023cites this paper
• New insights on the potential anti‐epileptic effect of metformin: Mechanistic pathway

  2023cites this paper
• Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension study

  2023cites this paper
• Increased vascular risk factors, atherosclerosis, and psychological distress among Indian adults with refractory epilepsy in comparison to well-controlled epilepsy.

  2023cites this paper
• Electrocardiogram Abnormalities and Associated Factors Among People with and without Epilepsy Attending the Outpatient Department at Referral Hospitals in Amhara Regional State, Northern Ethiopia, 2022: Institutional-Based Comparative Cross-Sectional Study

  2023cites this paper
• The effect of anti-seizure medications on lipid values in adults with epilepsy.

  2023cites this paper
• Effects of New Antiepileptic Drugs on Homocysteine in Epileptic Patients: A Systematic Review and Meta‐Analysis

  2023cites this paper
• Association of Long-term Antiseizure Medication Use and Incident Type 2 Diabetes Mellitus

  2023cites this paper
• Effects of Low- and High-Dose Valproic Acid and Lamotrigine on the Heart in Female Rats

  2022cites this paper
• Valproic acid as a radio-sensitizer in glioma: A systematic review and meta-analysis.

  2022cites this paper
• Statins in Epilepsy: From Mechanisms to Evidence

  2022cites this paper
• The Effects of Levetiracetam on the Histological Structure of the Brain and Some Biochemical Parameters in White Male Rats

  2022cites this paper
• Autonomic Measures in Differentiating Depressive Disorders: A Potential AID

  2022cites this paper
• Complications associated with the use of enzyme-inducing and non-enzyme-inducing anti-seizure medications in the Japanese population: A retrospective cohort study.

  2022cites this paper
• Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia

  2022cites this paper
• Epilepsy in elderly patients: does age of onset make a difference?

  2022cites this paper
• Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management

  2021cites this paper
• Risk of Cardiac Morbidities and Sudden Death in Patients With Epilepsy and No History of Cardiac Disease: A Population-Based Nationwide Study.

  2021cites this paper
• Frequency of metabolic syndrome and insulin resistance in epileptic patients treated with sodium valproate or carbamazepine monotherapy: A Case-Control Study 

  2021cites this paper
• Valproate is associated with early decrease of high‐density lipoprotein cholesterol levels in the psychiatric population

  2021cites this paper
• Drugs for patients with epilepsy and excessive daytime sleepiness.

  2021cites this paper
• Association between the Serum Coenzyme Q10 Level and Seizure Control in Patients with Drug-Resistant Epilepsy

  2021cites this paper
• Carotid intima-media and epicardial adipose tissue thickness in adult patients with epilepsy taking anti-seizure medication and its long-term significance.

  2021cites this paper
• Interictal autonomic dysfunction in patients with epilepsy

  2021cites this paper
• Sudep – Risk Factors, Protective Factors and Pathophysiological Mechanisms: a systematic review

  2021cites this paper
• Cardiac adverse effects of antiseizure medications

  2021influential citation
• Early detection of atherosclerotic changes associated with long use of antiepileptic drugs in epileptic patients

  2020cites this paper
• The Epileptic Heart: Concept and clinical evidence.

  2020cites this paper
• Cerebrovascular Disease; A Leading Cause of Epilepsy

  2020cites this paper
• Late-onset epilepsy predicts stroke: Systematic review and meta-analysis.

  2020cites this paper
• Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy.

  2020cites this paper
• Effect of valproic acid on overall survival in patients with high-grade gliomas undergoing temozolomide

  2020cites this paper
• Increased risk of stroke and myocardial infarction in patients with epilepsy: A systematic review of population-based cohort studies.

  2020cites this paper
• Epilepsy and Cardiovascular Function

  2020cites this paper
• Cardiovascular complications of epileptic seizures.

  2020influential citation
• Drug treatments in patients with cardiac diseases and epilepsy

  2020cites this paper
• Antiepileptic drug therapy in the elderly: a clinical pharmacological review

  2019cites this paper
• Effects of Prenatally Exposed Phenytoin Varying Doses on Fetal Growth of Albino Rats

  2019cites this paper
• Effects of valproic acid and levetiracetam monotherapy on carotid intima-media and epicardial adipose tissue thickness in non-obese children with epilepsy.

  2019cites this paper
• Epilepsy in elderly patients: does age of onset make a difference?

  2019cites this paper
• Blood Pressure in Seizures and Epilepsy

  2019cites this paper
• Epilepsy and heart diseases

  2019cites this paper
• Short-Term and Long-Term Effects of Levetiracetam Monotherapy on Homocysteine Metabolism in Children with Epilepsy: A Prospective Study

  2019cites this paper
• Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study.

  2019cites this paper
• Comorbidity between epilepsy and cardiac arrhythmias: Implication for treatment.

  2019cites this paper
• The Correlation between Old-Generation Antiepileptic Drugs Usage with Carotid Intima-Media Thickness in Epilepsy Patient

  2019cites this paper
• Kardiale und zerebrovaskuläre Erkrankungen bei Epilepsie

  2018cites this paper
• Assessment of components included in published societal perspective or QALY outcome economic analyses for antiepileptic drug treatment in chronic epilepsy

  2018cites this paper
• Stroke‐related epilepsy

  2018cites this paper
• The EEG in acute ischaemic cerebrovascular disease

  2018cites this paper
• Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters.

  2017cites this paper
• Gamma-glutamyltransferase and cardiovascular mortality in Korean adults: A cohort study.

  2017cites this paper
• The effects of lifestyle modification and statin therapy on the circulatory markers for vascular risk in patients with epilepsy.

  2017cites this paper
• Late-onset seizures, underlying etiology and antiepileptic drugs: A gordian knot?

  2017cites this paper
• The heart of epilepsy: Current views and future concepts.

  2017cites this paper
• Corpus callosotomy outcomes in paediatric patients

  2017cites this paper
• ASSESSMENT OF POTENTIAL EFFECT OF ANTIEPILPETIC DRUGS ON LIPID PROFILE AND C-REACTIVE PROTEIN AS PREDICTORS OF VASCULAR DISEASE IN EPILEPSY PATIENTS

  2017cites this paper
• Homocysteine and Non-Cardiac Vascular Disease.

  2017influential citation
• Metabolic effects of acute and chronic treatment with valproic acid in people with epilepsy

  2017cites this paper
• Nutritional status and metabolic profile in neurologically impaired pediatric surgical patients

  2017cites this paper
• Impact of age on cerebrovascular dilation versus reactivity to hypercapnia

  2017cites this paper
• Decrease in mortality of adult epilepsy patients since 1980: lessons learned from a hospital‐based cohort

  2017cites this paper
• Poststroke epilepsy: update and future directions

  2016influential citation
• Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.

  2016cites this paper
• Antiepileptic Drugs and Risk Factors of Vascular Diseases

  2016cites this paper
• THE PREDICTORS OF EARLY ATHEROSCLEROSIS IN YOUNG ADULT EPILEPTIC PATIENTS

  2016cites this paper
• Post-epilepsy stroke: A review

  2016cites this paper
• Aspectos dietéticos en el paciente epiléptico

  2015cites this paper
• Management of Epilepsy in People with Intellectual Disabilities

  2015cites this paper
• Cardiac functions of voltage-gated Ca(2+) channels: role of the pharmacoresistant type (E-/R-Type) in cardiac modulation and putative implication in sudden unexpected death in epilepsy (SUDEP).

  2014cites this paper
• Reviews of Physiology, Biochemistry and Pharmacology, Vol. 167

  2014cites this paper
• Enzyme-Inducing Anti-Seizure Medications Increase Risk of Ischemic Coronary and Cerebrovascular Diseases in the Long-Term

  year unknowncites this paper